Corton Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,278
| Closed | -$515K | – | 425 |
|
|
2024
Q4 | $515K | Buy |
+1,278
| New | +$515K | 0.3% | 12 |
|
|
2024
Q3 | – | Sell |
-613
| Closed | -$287K | – | 676 |
|
|
2024
Q2 | $287K | Sell |
613
-2,109
| -77% | -$989K | 0.15% | 211 |
|
|
2024
Q1 | $1.14M | Buy |
2,722
+733
| +37% | +$306K | 0.42% | 23 |
|
|
2023
Q4 | $809K | Buy |
1,989
+713
| +56% | +$290K | 0.26% | 75 |
|
|
2023
Q3 | $444K | Sell |
1,276
-701
| -35% | -$244K | 0.22% | 119 |
|
|
2023
Q2 | $696K | Buy |
1,977
+143
| +8% | +$50.3K | 0.33% | 56 |
|
|
2023
Q1 | $578K | Buy |
1,834
+1,038
| +130% | +$327K | 0.4% | 39 |
|
|
2022
Q4 | $230K | Buy |
+796
| New | +$230K | 0.19% | 184 |
|
|
2022
Q3 | – | Sell |
-1,299
| Closed | -$366K | – | 377 |
|
|
2022
Q2 | $366K | Sell |
1,299
-1,364
| -51% | -$384K | 0.35% | 103 |
|
|
2022
Q1 | $695K | Buy |
+2,663
| New | +$695K | 0.3% | 62 |
|